489
Views
4
CrossRef citations to date
0
Altmetric
Articles

Effect of pine-tar bath on disease severity in moderate-to-severe childhood eczema: an investigator-blinded, crossover, randomized clinical trial

, ORCID Icon, , , , , ORCID Icon & ORCID Icon show all
Pages 157-165 | Received 14 Nov 2019, Accepted 14 Feb 2020, Published online: 16 Apr 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kam Lun Ellis Hon, Vivian P Y Chan & Alexander K C Leung. (2021) Experimental Drugs with the Potential to Treat Atopic Eczema. Journal of Experimental Pharmacology 13, pages 487-498.
Read now

Articles from other publishers (3)

Miguel Ávalos‐Viveros, Roberto Esquivel‐García, Manuel García‐Pérez, Enelio Torres‐García, María‐Carmen Bartolomé‐Camacho, Víctor Santes & Martha‐Estrella García‐Pérez. (2022) Updated view of tars for psoriasis: what have we learned over the last decade?. International Journal of Dermatology 62:3, pages 290-301.
Crossref
Kam Lun Hon, Samantha Chu & Alexander K.C. Leung. (2022) Quality of Life for Children with Allergic Skin Diseases. Current Pediatric Reviews 18:3, pages 191-196.
Crossref
Jonwei Hwang, Alyssa Thompson, Joanna Jaros, Paul Blackcloud, Jennifer Hsiao & Vivian Y. Shi. (2021) Updated understanding of Staphylococcus aureus in atopic dermatitis: From virulence factors to commensals and clonal complexes . Experimental Dermatology 30:10, pages 1532-1545.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.